Evidence map›Paper›PMID 36136589›Full record

ArticleJCI insight2022

Iron accelerates Fusobacterium nucleatum-induced CCL8 expression in macrophages and is associated with colorectal cancer progression.

Taishi Yamane, Yohei Kanamori, Hiroshi Sawayama, Hiromu Yano, Akihiro Nita, Yudai Ohta, Hironori Hinokuma, Ayato Maeda, Akiko Iwai, Takashi Matsumoto and 12 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Iron, inflammation, and intestinal tumors: the crucial triad in colorectal cancer progression and therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Cancers · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Microbial manipulators:Journal of oral microbiology · 2025
    Review
  19. Article
  20. Identification of shared immune infiltration characteristic molecules in dermatomyositis and nasopharyngeal carcinoma using bioinformatics: Traits in dermatomyositis and nasopharyngeal cancer.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 3 countries.

Taishi YamaneDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Yohei KanamoriDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Hiroshi SawayamaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences.
Hiromu YanoDepartment of Cell Pathology, Graduate School of Medical Sciences, and.
Akihiro NitaDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Yudai OhtaDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Hironori HinokumaDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Ayato MaedaDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Akiko IwaiDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Takashi MatsumotoDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Mayuko ShimodaDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Mayumi NiimuraDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Shingo UsukiLiaison Laboratory Research Promotion Center, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Noriko Yasuda-YoshiharaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences.
Masato NiwaLaboratory of Pharmaceutical and Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.
Yoshifumi BabaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences.
Takatsugu IshimotoDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences.
Yoshihiro KomoharaDepartment of Cell Pathology, Graduate School of Medical Sciences, and.
Tomohiro SawaDepartment of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tasuku HirayamaLaboratory of Pharmaceutical and Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.
Hideo BabaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences.
Toshiro MoroishiDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences.
Toxicologie, Pharmacologie et Signalisation Cellulaire · FRKumamoto University · JPGifu Pharmaceutical University · JPInternational Network for Cancer Treatment and Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests that high levels of Fusobacterium nucleatum in colorectal tumor tissues can be associated with poor prognosis in patients with colorectal cancer (CRC); however, data regarding distinct prognostic subgroups in F. nucleatum-positive CRC remain limited. Herein, we demonstrate that high-iron status was associated with a worse prognosis in patients with CRC with F. nucleatum. Patients with CRC presenting elevated serum transferrin saturation exhibited preferential iron deposition in macrophages in the tumor microenvironment. In addition, F. nucleatum induced CCL8 expression in macrophages via the TLR4/NF-κB signaling pathway, which was inhibited by iron deficiency. Mechanistically, iron attenuated the inhibitory phosphorylation of NF-κB p65 by activating serine/threonine phosphatases, augmenting tumor-promoting chemokine production in macrophages. Our observations indicate a key role for iron in modulating the NF-κB signaling pathway and suggest its prognostic potential as a determining factor for interpatient heterogeneity in F. nucleatum-positive CRC.

Indexed as

Colorectal NeoplasmsFusobacterium InfectionsChemokine CCL8Fusobacterium nucleatumHumansIronMacrophagesNF-kappa BTumor MicroenvironmentCCL8 protein, humanChemokine CCL8IronNF-kappa BCancerMacrophagesOncology

Identifiers

PMID36136589
PMCPMC9675438
OpenAlexW4296688430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.